SV2008002856A - 2-AMINO-7, 8-DIHIDRO-6H-PIRIDO [4,3-D] PIRIMIDINA-5-ONAS - Google Patents
2-AMINO-7, 8-DIHIDRO-6H-PIRIDO [4,3-D] PIRIMIDINA-5-ONASInfo
- Publication number
- SV2008002856A SV2008002856A SV2008002856A SV2008002856A SV2008002856A SV 2008002856 A SV2008002856 A SV 2008002856A SV 2008002856 A SV2008002856 A SV 2008002856A SV 2008002856 A SV2008002856 A SV 2008002856A SV 2008002856 A SV2008002856 A SV 2008002856A
- Authority
- SV
- El Salvador
- Prior art keywords
- pirido
- dihidro
- amino
- compounds
- pirimidina
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
LOS COMPUESTOS REVELADOS SON 2-AMINO-7,8-DIHIDRO-6H-PIRIDO[4,3-D]PIRIMIDINA-5-UNO, SUS ESTEREOISÓMEROS, TAUTOMEROS, SALES ACEPTADAS FARMACÉUTICAMENTE, Y PRO-MEDICAMENTOS DE LO MISMO; LAS COMPOSICIONES QUE INCLUYEN UN PORTADOR FARMACÉUTICAMENTE ACEPTABLE Y UNO O MÁS DE LOS COMPUESTOS 2-AMINO-7,8-DIHIDRO-6H-PIRIDO[4,3-D]PIRIMIDINA-5-UNO, YA SEA SOLOS O EN COMBINACIÓN CON POR LO MENOS UN AGENTE TERAPÉUTICO ADICIONAL. SE REVELAN LOS MÉTODOS DE USO DE LOS COMPUESTOS 2-AMINO-7,8-DIHIDRO-6H-PIRIDO[4,3-D]PIRIMIDINA-5-UNO, YA SEA SOLOS O EN COMBINACIÓN CON POR LO MENOS UN AGENTE TERAPÉUTICO ADICIONAL, EN LA PROFILAXIS TRATAMIENTO DE LAS ENFERMEDADES DEL SISTEMA NERVIOSO CENTRAL, CARDIOVASCULARES, AUTOINMUNE, VIRALES, PROLIFERACIÓN CELULARTHE DISCLOSED COMPOUNDS ARE 2-AMINO-7,8-DIHIDRO-6H-PIRIDO [4,3-D] PYRIMIDINE-5-ONE, ITS STEREOISOMMERS, TAUTOMEROS, SALTS PHARMACUTICALLY ACCEPTED, AND PRO-MEDICATIONS OF THE SAME; COMPOSITIONS THAT INCLUDE A PHARMACEUTICALLY ACCEPTABLE CARRIER AND ONE OR MORE OF THE 2-AMINO-7,8-DIHIDRO-6H-PIRIDO [4,3-D] PIRIMIDINE-5-ONE COMPOUNDS, ALREADY ALONE OR IN COMBINATION WITH THEM LESS AN ADDITIONAL THERAPEUTIC AGENT. THE METHODS OF USE OF THE 2-AMINO-7,8-DIHIDRO-6H-PIRIDO [4,3-D] PIRIMIDINE-5-ONE COMPOUNDS, ALREADY ALONE OR IN COMBINATION WITH AT LEAST AN ADDITIONAL THERAPEUTIC AGENT, ARE DISCLOSED, IN THE PROFILAXIS TREATMENT OF THE DISEASES OF THE CENTRAL NERVOUS SYSTEM, CARDIOVASCULAR, AUTOINMUNE, VIRALS, CELL PROLIFERATION
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72279605P | 2005-09-30 | 2005-09-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
SV2008002856A true SV2008002856A (en) | 2008-06-30 |
Family
ID=40059303
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SV2008002856A SV2008002856A (en) | 2005-09-30 | 2008-03-28 | 2-AMINO-7, 8-DIHIDRO-6H-PIRIDO [4,3-D] PIRIMIDINA-5-ONAS |
Country Status (6)
Country | Link |
---|---|
CN (1) | CN101287734B (en) |
AR (1) | AR110068A2 (en) |
SI (1) | SI1928875T1 (en) |
SV (1) | SV2008002856A (en) |
UA (1) | UA93522C2 (en) |
ZA (1) | ZA200803658B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113056475A (en) * | 2018-11-30 | 2021-06-29 | 中外制药株式会社 | Deprotection method for peptide compound or amide compound and resin removal method in solid phase reaction and method for producing peptide compound |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012503619A (en) * | 2008-09-26 | 2012-02-09 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | Host cell kinases as targets for antiviral therapy against HCV infection |
CN102227227B (en) * | 2008-11-28 | 2014-05-28 | 诺华股份有限公司 | Pharmaceutical combination comprising hsp90 and her2 inhibitors derived from pyridino-[4, 3-d]pyrimidine |
CA2744937C (en) * | 2008-11-28 | 2017-02-28 | Novartis Ag | Pharmaceutical combination comprising a hsp 90 inhibitor and a mtor inhibitor |
WO2016177655A1 (en) * | 2015-05-04 | 2016-11-10 | F. Hoffmann-La Roche Ag | Tetrahydropyridopyrimidines and tetrahydropyridopyridines as inhibitors of hbsag (hbv surface antigen) and hbv dna production for the treatment of hepatitis b virus infections |
CN109846886A (en) * | 2019-03-26 | 2019-06-07 | 中国医学科学院基础医学研究所 | Purposes of the NVP-HSP990 in the drug of preparation treatment epilepsy |
CN114681463B (en) * | 2022-04-29 | 2024-03-15 | 暨南大学 | Application of HSP990 in preparing medicine for preventing and/or treating adenovirus infection |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6165873A (en) * | 1984-09-07 | 1986-04-04 | Mitsui Petrochem Ind Ltd | 2-piperazinopyrimidine derivative |
US4734418A (en) * | 1984-12-14 | 1988-03-29 | Mitsui Petrochemical Industries, Ltd. | Quinazoline compounds and antihypertensives |
IL85347A0 (en) * | 1987-02-11 | 1988-07-31 | May & Baker Ltd | Cyclic diones |
-
2006
- 2006-09-28 CN CN2006800365004A patent/CN101287734B/en not_active Expired - Fee Related
- 2006-09-28 UA UAA200805390A patent/UA93522C2/en unknown
- 2006-09-28 SI SI200631090T patent/SI1928875T1/en unknown
-
2008
- 2008-03-28 SV SV2008002856A patent/SV2008002856A/en active IP Right Grant
- 2008-04-25 ZA ZA200803658A patent/ZA200803658B/en unknown
-
2017
- 2017-11-13 AR ARP170103158A patent/AR110068A2/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113056475A (en) * | 2018-11-30 | 2021-06-29 | 中外制药株式会社 | Deprotection method for peptide compound or amide compound and resin removal method in solid phase reaction and method for producing peptide compound |
Also Published As
Publication number | Publication date |
---|---|
UA93522C2 (en) | 2011-02-25 |
ZA200803658B (en) | 2009-09-30 |
CN101287734A (en) | 2008-10-15 |
SI1928875T1 (en) | 2011-10-28 |
CN101287734B (en) | 2011-07-20 |
AR110068A2 (en) | 2019-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP088324A (en) | 2-AMINO-7,8-DIHIDRO-6H-PIRIDO [4,3-D] PIRIMIDINA-5-ONAS | |
CL2008001745A1 (en) | Compounds derived from imidazo [1,2-a] pyrazine; pharmaceutical composition; and use of the compounds as protein kinase inhibitors in the treatment of cancer. | |
UY28941A1 (en) | REPLACED INDAZOLS, COMPOSITIONS THAT CONTAIN THEM, PREPARATION PROCEDURE AND ITS USE | |
CL2007002062A1 (en) | Compounds derived from [1,2,4] triazolo [4,3-a] pyridine, kinase inhibitors; pharmaceutical composition; and its use in the treatment of cancer. | |
SV2008002856A (en) | 2-AMINO-7, 8-DIHIDRO-6H-PIRIDO [4,3-D] PIRIMIDINA-5-ONAS | |
BRPI0510170B8 (en) | compound, pharmaceutical composition for the treatment of diseases mediated by the muscarinic acetylcholine receptor and use of the compound | |
BRPI0616630B8 (en) | substituted pyrazole compounds | |
UY27729A1 (en) | QUINASE INHIBITORS. | |
UY27943A1 (en) | COMPOSITIONS AND METHODS TO TREAT CRNCER USING ANTIBODY IMMUNOCATE PLAYS FOR CD44 CYTOTNXICS AND CHEMOTHERAPCUTIC AGENTS | |
CL2008001540A1 (en) | Compounds derived from pyrrolopyridines and pyrazolopyridines; pharmaceutical composition; and use in the treatment of cancer. | |
CR6577A (en) | TRICYCLE POLY INHIBITORS (ADP-RIBOSA) POLYMERASES | |
CL2008001946A1 (en) | Imidazole-derived compounds, ccr2, ccr3, ccr5 receptor antagonists; preparation procedure; and use in the treatment of peripheral vascular diseases. | |
BRPI0409133A (en) | pharmaceutical formulations containing methylnaltrexone | |
CL2008002139A1 (en) | Dimer compounds derived from pyrrolo [2,1c] [1,4] benzodiazepine-5 -one (tomaimycin), a conjugate comprising them; procedure of preparation of conjugates; pharmaceutical composition comprising the compounds or conjugates; and use of compounds and conjugates in the treatment of cancer. | |
CL2008001932A1 (en) | Compounds derived from 6-cycloamino-3- (pyridin-4-yl) imidazo [1,2-b] pyridazine, cq1epsilon and / or ck1delta inhibitors; preparation procedure; pharmaceutical composition comprising them; and use in the treatment of sleep disorders, circadian rhythm disorder, cancer, and Alzheimer's disease. | |
UY29087A1 (en) | ADAMANTILE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USE | |
CL2008003846A1 (en) | Use of compounds derived from 1,2,4-triazolo fused with heterocycles, which act as ligands of the androgen receptor (ar); compounds; Preparation process; Pharmaceutical composition and the use of said compounds for the treatment of prostate cancer. | |
CL2008001813A1 (en) | COMPOUNDS DERIVED FROM QUINOLIN-3-CARBONITRILE SUBSTITUTED WITH PIPERAZINE; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS ARTHRITIS, INFLAMMATION, CANCER BETWEEN OTHERS (DIV. SOL. 266-04). | |
BRPI0412993A (en) | akt activity inhibitors | |
CL2008001626A1 (en) | Compounds derived from fused heterocycles, a pharmaceutical agent that comprises them and their use in the prophylaxis and treatment of cancer. | |
ECSP045286A (en) | INDAZOLS REPLACED WITH AN ANTI-TARGET ACTIVITY | |
CL2011000729A1 (en) | Compounds derived from methanopyrazolo [3,4-e] [1,3] diazepine; preparation procedure; pharmaceutical composition comprising them; and its use in the treatment of bacterial infections. | |
CL2007001710A1 (en) | Substituted amino-pyrazolopyridine derivatives; Preparation method; pharmaceutical composition; and use in the treatment of diseases such as tumors, rheumatoid arthritis, diseases of deregulated vascular growth, among others. | |
DE502004002571D1 (en) | SUBSTITUTED 3-PYRROLIDIN INDOL DERIVATIVES | |
ATE425982T1 (en) | THIENOPYRIMIDINE DERIVATIVES AS POTASSIUM CHANNEL INHIBITORS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant |